Activation of p53 transcriptional activity requires ATM's kinase domain and multiple N-terminal serine residues of p53
The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
The ATM protein kinase regulates the cell's response to DNA damage by regulating cell cycle checkpoints and DNA repair. ATM phosphorylates several proteins involved in the DNA-damage response, including p53. We have examined the mechanism by which ATM regulates p53's transcriptional activity. Here, we demonstrate that reintroduction of ATM into AT cells restores the activation of p53 by the radio-mimetic agent bleomycin. Further, p53 activation is lost when a kinase inactive ATM is used, or if the N-terminal of ATM is deleted. In addition, AT cells stably expressing ATM showed decreased sensitivity to Ionizing Radiation-induced cell killing, whereas cells expressing kinase inactive ATM or N-terminally deleted ATM were indistinguishable from AT cells. Finally, single point-mutations of serines 15, 20, 33 or 37 did not individually block the ATM-dependent activation of p53 transcriptional activity by bleomycin. However, double mutations of either serines 15 and 20 or serines 33 and 37 blocked the ability of ATM to activate p53. Our results indicate that the N-terminal of ATM and ATM's kinase activity are required for activation of p53's transcriptional activity and restoration of normal sensitivity to DNA damage. In addition, activation of p53 by ATM requires multiple serine residues in p53's transactivation domain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When the cell’s repair mechanisms become overwhelmed, the activated DDR elicits cellular senescence via phosphorylation of p53 [33].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [33]
Citations
Cites
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 2×
“Degradation of p53 is mediated by the mdm2 oncogene (Haupt et al., 1997; Kubbutata et al., 1998), such that mdm2-p53 complexes are targeted for ubiquitin dependent degradation.”
BackgroundKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 4×
“In AT cells, activation of p53 is defective, and there is little or no increase in transcriptional activity (Kastan et al., 1991, 1992).”
BackgroundInfluentialDNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100 · cited 7×
“There are additional sites for DNA damage induced phosphorylation at serines 33 and 37 of p53 (Sakaguchi et al., 1998; Shieh et al., 1997; 1999; Siliciano et al., 1997), which may be regulated by Atr and other kinases (Hall-Jackson et al., 1999; Tibbets et al., 1999).”
BackgroundResultInfluentialActivation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase
Matsuoka, S. (1998) · Science · doi:10.1126/science.282.5395.1893 · Cited by 1,322 · cited 3×
“…gene (Banin et al., 1998; Canman et al., 1998; Kastan et al., 1991; 1992) and the checkpoint kinase chk2 (Blasina et al., 1999a; Brown et al., 1999; Matsuoka et al., 1998). chk2 is involved in the activation of the G2checkpoint (Blasina et al., 1999b; Brown et al., 1999; Matsuoka et al., 1999).”
BackgroundMethodDNA Damage-Induced Activation of p53 by the Checkpoint Kinase Chk2
Hirao, A., Kong, Y.-Y., Matsuoka, S., Wakeham, A., Ruland, J., Yoshida, H., Liu, D., Elledge, S. J., & Mak, T. W. (2000) · Science · doi:10.1126/science.287.5459.1824 · Cited by 1,285 · cited 3×
“Second, ATM activates chk2 kinase which can phosphorylate serine 20 of p53 (Chebab et al., 2000; Hirao et al., 2000; Tominaga et al., 1999).”
BackgroundDNA damage activates p53 through a phosphorylation–acetylation cascade
Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., & Appella, E. (1998) · Genes & Development · doi:10.1101/gad.12.18.2831 · Cited by 1,204 · cited 19×
“There are additional sites for DNA damage induced phosphorylation at serines 33 and 37 of p53 (Sakaguchi et al., 1998; Shieh et al., 1997; 1999; Siliciano et al., 1997), which may be regulated by Atr and other kinases (Hall-Jackson et al., 1999; Tibbets et al., 1999).”
BackgroundResultInfluentialOda, K., Arakawa, H., Tanaka, T., Matsuda, K., Tanikawa, C., Mori, T., Nishimori, H., Tamai, K., Tokino, T., Nakamura, Y., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00073-8 · Cited by 1,172 · cited 1×
“There are also other phosphorylation sites within p53 N-terminal which can be regulated by DNA damage, including serines 6 and 9 (Higashimoto et al., 2000) and serine 46 (Oda et al., 2000), which may contribute to the overall activation of p53.”
BackgroundA role for ATR in the DNA damage-induced phosphorylation of p53
Tibbetts, R. S., Brumbaugh, K. M., Williams, J. M., Sarkaria, J. N., Cliby, W. A., Shieh, S.-Y., Taya, Y., Prives, C., & Abraham, R. T. (1999) · Genes & Development · doi:10.1101/gad.13.2.152 · Cited by 1,046
Cited by
Hallmarks of Cellular Senescence
Hernandez-Segura, A., Nehme, J., & Demaria, M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.02.001 · Cited by 2,605
“The persistence of DDR induces the phosphorylation of p53 at multiple serine residues, which enhances the ability of p53 to induce the transcription of many genes [15].”
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
Mateo, J., Carreira, S., Sandhu, S., Miranda, S., Mossop, H., Perez-Lopez, R., Nava Rodrigues, D., Robinson, D., Omlin, A., Tunariu, N., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506859 · Cited by 2,185
Living on a break: cellular senescence as a DNA-damage response
d'Adda di Fagagna, F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2440 · Cited by 1,170
Senescence and cancer — role and therapeutic opportunities
Schmitt, C. A., Wang, B., & Demaria, M. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00668-4 · Cited by 794
A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM
Sun, Y., Jiang, X., Chen, S., Fernandes, N., & Price, B. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504211102 · Cited by 738
Self-citationFei, P., & El-Deiry, W. S. (2003) · Oncogene · doi:10.1038/sj.onc.1206677 · Cited by 498
“The phenomenon that cells lacking ATM showed a reduced and delayed activation of P53 in response to DNA damage (el Khodairy et al., 1992) implied that P53 function in response to IR was ATM dependent; this is known as a fact (Canman et al., 1998; Turenne et al., 2001).”
BackgroundDNA damage-induced activation of ATM and ATM-dependent signaling pathways
Kurz, E. U., & Lees-Miller, S. P. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.029 · Cited by 478
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
“When the cell’s repair mechanisms become overwhelmed, the activated DDR elicits cellular senescence via phosphorylation of p53 [33].”
BackgroundSkin Aging, Cellular Senescence and Natural Polyphenols
Csekes, E., & Račková, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312641 · Cited by 320
DNA Damage-Induced Acetylation of Lysine 3016 of ATM Activates ATM Kinase Activity
Sun, Y., Xu, Y., Roy, K., & Price, B. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01382-07 · Cited by 319
“Interestingly, ATMkd, which does not possess kinase activity and does not autophosphorylate (40), was also acetylated.”
BackgroundSelf-citationATM and ATR signaling at a glance
Awasthi, P., Foiani, M., & Kumar, A. (2015) · Journal of Cell Science · doi:10.1242/jcs.169730 · Cited by 271
“, 2011), and activation of p53, NF-κB and microRNAs (Turenne et al., 2001; Wu et al., 2006; Zhang et al., 2011) in order to regulate the transcription of genes that are needed to modulate cell responses following DNA damage (see poster).”
Backgroundp53 at the crossroad of DNA replication and ribosome biogenesis stress pathways
Lindström, M. S., Bartek, J., & Maya-Mendoza, A. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00999-w · Cited by 159
“The checkpoint-induced p53 transcriptional activation requires ATM and CHK2-dependent phosphorylation at S15 and S20, respectively [24, 25].”
BackgroundProlyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer
Ryo, A., Liou, Y.-C., Lu, K. P., & Wulf, G. (2003) · Journal of Cell Science · doi:10.1242/jcs.00276 · Cited by 173
“…critically on its phosphorylation on multiple serine/threonine residues, including those preceding prolines (Abraham et al., 2000; Blaydes et al., 2001; Bulavin et al., 1999; Buschmann et al., 2001; Milner et al., 1990; Sakaguchi et al., 1998; SanchezPrieto et al., 2000; Turenne et al., 2001).”
BackgroundJiang, X., Sun, Y., Chen, S., Roy, K., & Price, B. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513172200 · Cited by 136
Self-citationRole of Cellular Senescence in Type II Diabetes
Narasimhan, A., Flores, R. R., Robbins, P. D., & Niedernhofer, L. J. (2021) · Endocrinology · doi:10.1210/endocr/bqab136 · Cited by 133
Cellular senescence: a promising strategy for cancer therapy
Lee, S., & Lee, J.-S. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.1.294 · Cited by 115
“such activated DDR machinery induces phosphorylation of p53 at multiple sites, and activated p53 induces cell cycle arrest through the transcription of downstream targets (19, 21).”
Background(2003) · PubMed · Cited by 105
Role of Cyclin B1 Levels in DNA Damage and DNA Damage-Induced Senescence
Nakayama, Y., & Yamaguchi, N. (2013) · International review of cytology · doi:10.1016/b978-0-12-407695-2.00007-x · Cited by 112
Cell cycle dysregulation in cancer
Glaviano, A., Singh, S. K., Lee, E. H. C., Okina, E., Lam, H. Y., Carbone, D., Reddy, E. P., O’Connor, M. J., Koff, A., Singh, G., et al. (2024) · Pharmacological Reviews · doi:10.1016/j.pharmr.2024.100030 · Cited by 110
Chen, K., Albano, A., Ho, A., & Keaney, J. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304423200 · Cited by 95
Wichmann, A., Jaklevic, B. R., & Su, T. T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510528103 · Cited by 90
Cellular senescence: a hitchhiker’s guide
Aravinthan, A. (2015) · Human Cell · doi:10.1007/s13577-015-0110-x · Cited by 72
“First, there is rapid cell cycle arrest caused by destruction of CDC25 (mediated by Chk1), which is followed by induction and stabilisation of p53, which leads to stable cell cycle arrest [109, 110].”
BackgroundNitric oxide induces phosphorylation of p53 and impairs nuclear export
Schneiderhan‐Marra, N., Budde, A., Zhang, Y., & Brüne, B. (2003) · Oncogene · doi:10.1038/sj.onc.1206431 · Cited by 83
“Studies with p53 N-terminal mutations at serines 15, 20, 33 or 37 indicated multiple and functionally overlapping phosphorylation sites to control p53 activity in response to DNA damage (Shieh et al., 1997; Dumaz and Meek, 1999; Hirao et al., 2000; Turenne et al., 2001).”
BackgroundATM and ATR signaling at a glance
Awasthi, P., Foiani, M., & Kumar, A. (2016) · Journal of Cell Science · doi:10.1242/jcs.188631 · Cited by 84
Cellular senescence in the aging brain: A promising target for neurodegenerative diseases
Sahu, M. R., Rani, L., Subba, R., & Mondal, A. C. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111675 · Cited by 75
Fernandes, N., Sun, Y., Chen, S., Paul, P., Shaw, R. J., Cantley, L. C., & Price, B. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412065200 · Cited by 70
Self-citationSenescence in chronic wounds and potential targeted therapies
Wei, X., Li, M., Zheng, Z., Ma, J., Gao, Y., Chen, L., Peng, Y., Yu, S., & Yang, L. (2022) · Burns & Trauma · doi:10.1093/burnst/tkab045 · Cited by 73
“The DDR initiates cellular senescence and cyclin-dependent kinase inhibitors (CDKI) are involved in the process.”
InfluentialGaul, L., Mandl–Weber, S., Baumann, P., Emmerich, B., & Schmidmaier, R. (2007) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0278-x · Cited by 71
“Furthermore, ATM is able to activate the tumor suppressor p53 on several serine residues (Canman et al. 1998; Turenne et al. 2001; Miyakoda et al. 2002).”
Functional consequences of sequence alterations in the ATM gene
Lavin, M. F., Scott, S. P., Gueven, N., Kozlov, S., Peng, C., & Chen, P. (2004) · DNA repair · doi:10.1016/j.dnarep.2004.03.011 · Cited by 75
Methylation of the ATM promoter in glioma cells alters ionizing radiation sensitivity
Roy, K., Wang, L., Makrigiorgos, G. M., & Price, B. D. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.222 · Cited by 66
Self-citationOhki, R., Kawase, T., Ohta, T., Ichikawa, H., & Taya, Y. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2006.00375.x · Cited by 60
Kennedy, D. R., Gawron, L. S., Ju, J., Liu, W., Shen, B., & Beerman, T. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2893 · Cited by 55
Innate immune response orchestrates phosphoribosyl pyrophosphate synthetases to support DNA repair
Liu, R. R., Li, J., Shao, J., Lee, J.-H., Qiu, X., Xiao, Y., Zhang, B., Hao, Y., Li, M., & Chen, Q. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.07.009 · Cited by 51
Roles of ATM and ATR in DNA double strand breaks and replication stress
Williams, R. M., & Zhang, X. (2020) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2020.11.005 · Cited by 51
Haneda, M., Kojima, E., Nishikimi, A., Hasegawa, T., Nakashima, I., & Isobe, K.-I. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.04.066 · Cited by 43
Ataxia-Telangiectasia Mutated Modulation of Carbon Metabolism in Cancer
Dahl, E. S., & Aird, K. M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00291 · Cited by 47
“Finally, the N-terminus of ATM encompasses HEAT (huntingtin, elongation factor 3, A subunit of protein phosphatase 2A, and TOR1) repeats, which form helices that interact with various macromolecules and play a role in ATM’s kinase function (10, 11).”
BackgroundGatti, L., Supino, R., Perego, P., Pavesi, R., Caserini, C., Carenini, N., Righetti, S. C., Zuco, V., & Zunino, F. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401109 · Cited by 49
“Cisplatin-induced apoptosis was associated with a marked induction of p53 expression and phosphorylation of Ser15.”
BackgroundThe switch from survival responses to apoptosis after chromosomal breaks
Bree, R. T., Neary, C. L., Samali, A., & Lowndes, N. F. (2004) · DNA repair · doi:10.1016/j.dnarep.2004.03.016 · Cited by 55
Roles of ATM and ATR in DNA double strand breaks and replication stress
Williams, R. M., & Zhang, X. (2021) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2021.03.007 · Cited by 41
DNA damage response in adult stem cells
Insinga, A., Cicalese, A., & Pelicci, P. G. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2013.12.005 · Cited by 41
“Ultimately, activation of the DDR signaling cascade converges upon the key decision-making factor p53 [2,14].”
BackgroundTuresson, R. B. I. (2001) · Acta Oncologica · doi:10.1080/02841860152708224 · Cited by 41
Mamun, A. A., Sufian, M. A., Uddin, M. S., Sumsuzzman, D. M., Jeandet, P., Islam, M. S., Zhang, H., Kong, A. T., & Sarwar, M. S. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174991 · Cited by 41
McMurray, H. R., & McCance, D. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5698-5706.2004 · Cited by 40
“In response to other DNA damage signals, such as UV irradiation or chemotherapeutic agents, cells arrest upon damage to attempt to repair it (31, 40, 66, 84, 103, 104, 110, 111).”
BackgroundInfluentialCellular senescence and failure of myelin repair in multiple sclerosis
Koutsoudaki, P. N., Papadopoulos, D., Passias, P.-G., Koutsoudaki, P., & Gorgoulis, V. G. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111366 · Cited by 33
“Most of these triggers lead to DNA damage and typically activate the complex signal transduction system of DNA damage response (DDR), which may elicit CS (Nakamura et al., 2008; Rodier and Campisi, 2011; Turenne et al., 2001).”
Immunosenescence promotes cancer development: from mechanisms to treatment strategies
Wang, L., & Tang, D. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02082-6 · Cited by 38
“Activation of p53, triggered by the DNA damage response (DDR) signaling cascade, results in cell cycle arrest [12, 13].”
Tchivilev, I., Madamanchi, N. R., Vendrov, A. E., Niu, X.-L., & Runge, M. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803452200 · Cited by 33
Stable siRNA-mediated silencing of ATM alters the transcriptional profile of HeLa cells
Chen, S., Wang, G., Makrigiorgos, G. M., & Price, B. D. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.149 · Cited by 32
Self-citationGötz, C., Bachmann, C., & Montenarh, M. (2006) · The Prostate · doi:10.1002/pros.20471 · Cited by 30
“Deletion of the enzyme in yeast leads to a non-viable phenotype [15], depletion of the enzyme in mammalian cells by antisense technology [16], or microinjection of antibodies leads to growth arrest at defined phases in the cell cycle [17].”
BackgroundCarbone, R., Giorgetti, L., Zanardi, A., Marangi, I., Chierici, E., Bongiorno, G. A., Fiorentini, F., Faretta, M., Piseri, P., Pelicci, P. G., et al. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.12.026 · Cited by 29
Andrews, J. L., Goodfellow, F. J., Matosin, N., Snelling, M., Newell, K. A., Huang, X., & Fernandez, F. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.01.009 · Cited by 31
TP53 and TP53-Related Genes Associated with Protection from Apoptosis in the Radioadaptive Response
Okazaki, R., Ootsuyama, A., & Norimura, T. (2007) · Radiation Research · doi:10.1667/rr0623.1 · Cited by 28
Choudhury, G. G. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(02)00057-8 · Cited by 28
Glucose Tolerance in Mice is Linked to the Dose of the p53 Transactivation Domain
Franck, D., Tracy, L., Armata, H. L., Delaney, C. L., Jung, D. Y., Ko, H. J., Ong, H., Kim, J. K., Scrable, H. J., & Sluss, H. K. (2012) · Endocrine Research · doi:10.3109/07435800.2012.735735 · Cited by 27
“The effect can be compared to effect of the Ser(18) mutation on the activity of the p53 transcription factor (31).”
BackgroundPrincipal Aspects Regarding the Maintenance of Mammalian Mitochondrial Genome Integrity
Vasileiou, P. V. S., Mourouzis, I. S., & Pantos, C. I. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081821 · Cited by 31
“indirectly regulates serine-20 phosphorylation by controlling activation of the checkpoint kinase chk2, thus impeding the interaction of p53 with MDM2 and, therefore increasing the stability of the p53 protein and activating its transcriptional activity [156].”
BackgroundEnsuring the Stability of the Genome: DNA Damage Checkpoints
Latif, C., Harvey, S. H., & O'Connell, S. J. (2001) · The Scientific World JOURNAL · doi:10.1100/tsw.2001.297 · Cited by 32
“Initial studies indicated that ATM was required for the stabilisation of p53 by phosphorylation at serine-15 (S15)[47].”
BackgroundExpression of ATM Protein and Its Relationship With p53 in Pancreatic Carcinoma With Tissue Array
Yu, G., Zhu, M.-H., Zhu, Z., Ni, C.-R., Zheng, J., & Li, F.-M. (2004) · Pancreas · doi:10.1097/00006676-200405000-00011 · Cited by 25
Pharmacological inhibition of ATM by KU55933 stimulates ATM transcription
Khalil, H. S., Tummala, H., Hupp, T. R., & Zhelev, N. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.011378 · Cited by 25
Small-molecule fluorescence-based probes for aging diagnosis
Shi, D., Liu, W., Wang, G., Guo, Y., & Li, J. (2022) · Acta Materia Medica · doi:10.15212/amm-2021-0004 · Cited by 28
“The persistent DNA-damage response induces the phosphorylation of histone H2AX and p53; therefore, γH2AX nuclear foci and phosphorylated p53 are commonly used as age-related biomarkers [7, 8].”
BackgroundSeidel, J. J., Anderson, C. M., & Blackburn, E. H. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00326-08 · Cited by 29
“The mammalian ATM N terminus is important for regulating the response to DNA damage (12, 40), and regions of it have been reported to interact with protein partners (4, 11, 15, 20, 37), associate with chromatin (43), and regulate the nuclear localization of ATM (43).”
BackgroundFunctional assessment of all ATM SNVs using prime editing and deep learning
Lee, K. S., Min, J.-G., Cheong, Y., Oh, H.-C., Jung, S.-Y., Park, J., Song, M., Seo, J. H., Cho, S., & Kim, S. (2025) · Cell · doi:10.1016/j.cell.2025.05.046 · Cited by 25
Macha, S. J., Koneru, B., Burrow, T. A., Zhu, C., Savitski, D., Rahman, R. L., Ronaghan, C. A., Nance, J., McCoy, K., Eslinger, C. R., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0125 · Cited by 28
Yoshikawa, Y., Hirata, N., Terada, H., Sawashita, Y., & Yamakage, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071614 · Cited by 22
“network analysis revealed 4 hub genes (deep blue nodes) including Atm, which has been considered to be an important regulator of the p53 signaling pathway [37] (Figure 5B, Table 2).”
BackgroundKim, B. J. (2002) · Carcinogenesis · doi:10.1093/carcin/23.9.1411 · Cited by 26
Role of JNK and p38 MAPK in Taiwanin A-induced cell death
Ho, P.-J., Chou, C., & Yeh, S.-F. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.10.007 · Cited by 21
Eskndir, N., Hossain, M., Currey, M. L., Pho, M., Berrada, Y., Lin, K. Y., Manning, G., Prince, K., & Stephens, A. D. (2024) · Molecular Biology of the Cell · doi:10.1091/mbc.e24-05-0232 · Cited by 20
“There is well-established mechanism for changes in heterochromatin driven by ATM which is activated by DNA damage from both CSP (Colton et al. , 2006) and BLE (Turenne et al. , 2001).”
Xuan, L., Xiaojie, Q., Yu, H., Jialiang, C., Jinming, G., & Chang, Y. (2022) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2022.02.002 · Cited by 20
Cowman, S. J., Pizer, B. L., & Sée, V. (2021) · PeerJ · doi:10.7717/peerj.11275 · Cited by 20
Chen, S., Paul, P., & Price, B. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206760 · Cited by 24
“Further, genetic inactivation of ATM’s kinase activity inhibits all of ATM’s function (Turenne et al., 2001), indicating that the kinase activity of ATM is an essential component of the signal transduction pathway by which ATM activates the DNA damage response.”
BackgroundMethodResultInfluentialSelf-citationTumor Suppressor p53 Regulates Heat Shock Factor 1 Protein Degradation in Huntington's Disease
Mansky, R. H., Greguske, E. A., Yu, D., Zarate, N., Intihar, T. A., Tsai, W., Brown, T. G., Thayer, M. N., Kumar, K., & Gómez‐Pastor, R. (2022) · Cell Reports · doi:10.1016/j.celrep.2023.112198 · Cited by 20
Epistatic interactions between NMD and TRP53 control progenitor cell maintenance and brain size
Lin, L., Zhao, J., Kubota, N., Li, Z., Lam, Y.-L., Nguyen, L. P., Yang, L., Pokharel, S. P., Blue, S. M., Yee, B. A., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.04.006 · Cited by 18
Mavuluri, J., Beesetti, S., Surabhi, R. P., Kremerskothen, J., Venkatraman, G., & Rayala, S. K. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.01004-15 · Cited by 18
Zhang, T., Luu, M. D. A., Dolga, A. M., Eisel, U. L. M., & Schmidt, M. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1207280 · Cited by 21
“ROS and other stressors can damage DNA and subsequently trigger DNA damage response (DDR) to phosphorylate a cell cycle repressor, p53 (Ramirez et al., 2001; Turenne et al., 2001; Nakamura et al., 2008).”
BackgroundCellular Senescence and Ageing
Reed, R., & Miwa, S. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-21410-3_7 · Cited by 16
Edaravone, a known free radical scavenger, enhances X-ray-induced apoptosis at low concentrations
Sasano, N., Enomoto, A., Hosoi, Y., Katsumura, Y., Matsumoto, Y., Morita, A., Shiraishi, K., Miyagawa, K., Igaki, H., & Nakagawa, K. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.12.020 · Cited by 16
“The phosphorylation of p53 at Ser 15 or Ser 20 has been shown to be mediated by the ATM, leading to p53 activation [20].”
BackgroundDu, F., Zhang, M., Li, X., Yang, C., Meng, H., Wang, D., Chang, S., Xu, Y., Price, B. D., & Sun, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.09.038 · Cited by 17
“Previous work showed that the 350amino-acid kinase domain located at the carboxy terminus of ATM and the kinase dead mutation the ATMKD does not possess kinase activity and does not autophosphorylate [17,22].”
BackgroundSelf-citationIL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy
Romaniello, D., Gelfo, V., Pagano, F., Sgarzi, M., Morselli, A., Girone, C., Filippini, D. M., D’Uva, G., & Lauriola, M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1083743 · Cited by 15
“Finally, the recruitment of several DDR mediators at the site of DNA damage culminates in the activation of decision-making factors, such as p53 and the cell-division cycle 25 (CDC25) phosphatases (Mailand et al., 2000; Turenne et al., 2001).”
BackgroundJaylet, T., Quintens, R., Armant, O., & Audouze, K. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1197204 · Cited by 13
Flip a coin: cell senescence at the maternal–fetal interface
Gong, G.-S., Muyayalo, K. P., Zhang, Y., Lin, X., & Liao, A. (2023) · Biology of Reproduction · doi:10.1093/biolre/ioad071 · Cited by 14
“X variant histone (H2AX), tumor protein p53 (p53), and DNA repair complexes assemble to repair broken double-stranded DNA [21, 22].”
BackgroundTabaa, M. M. E., Tabaa, M. M. E., Rashad, E., Elballal, M. S., & Elazazy, O. E. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111954 · Cited by 14
Involvement of ATM/ATR-p38 MAPK cascade in MNNG induced G1-S arrest
Zhu, K., & Zhang, S.-J. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i9.2073 · Cited by 15
Rogatcheva, M. B., Fritz, K. L., Rund, L. A., Pollock, C. B., Beever, J. E., Counter, C. M., & Schook, L. B. (2007) · Gene · doi:10.1016/j.gene.2007.08.014 · Cited by 11
“It has been shown that in humans the deletion of only this domain diminished ATM involved cell responses to DNA damage caused by bleomicin (Turenne et al., 2001).”
BackgroundHe, G., Tang, A., Xie, M., Xia, W., Zhao, P., Wei, J., Lai, Y., Tang, X., Zou, Y. M., & Liu, H. (2020) · Dose-Response · doi:10.1177/1559325820914184 · Cited by 11
Nanomaterials intervene in cell senescence to reinforce cancer therapy
Sun, S., Yang, N., Nie, J., Yang, Z., Pei, Z., Ding, R., & Cheng, L. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217012 · Cited by 10
ATM and ATR checkpoint kinase pathways: A concise review
Chauhan, N., Wagh, V., Joshi, P., & Jariyal, H. (2020) · Advances in Human Biology · doi:10.4103/aihb.aihb_78_19 · Cited by 11
NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma
Kennedy, B. E., Giacomantonio, M., Murphy, J. P., Cutler, S. D., Sadek, M., Konda, P., Paulo, J. A., Pathak, G. P., Renkens, S. H. J., Grieve, S., et al. (2022) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2022.02.017 · Cited by 11
p53: Balancing tumour suppression and implications for the clinic
Buganim, Y., & Rotter, V. (2009) · European Journal of Cancer · doi:10.1016/s0959-8049(09)70037-1 · Cited by 10
MDM4 expression in fibrolamellar hepatocellular carcinoma
Karki, A., Putra, J., Kim, S. M., LaQuaglia, M. P., Pérez‐Atayde, A. R., Sadri‐Vakili, G., & Vakili, K. (2019) · Oncology Reports · doi:10.3892/or.2019.7241 · Cited by 9
Targeting ATR-CHK1 and ATM-CHK2 Axes in Pancreatic Cancer—A Comprehensive Review of Literature
Kciuk, M., Wanke, K., Marciniak, B., Kołat, D., Aleksandrowicz, M., Mujwar, S., Ainane, T., & Kontek, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031152 · Cited by 9
Porcelli, G., D’Accardo, C., Angeloro, F., Cucchiara, M., Bianca, P., Pantina, V. D., Roozafzay, N., Modica, C., Gaggianesi, M., Bella, S. D., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02499-0 · Cited by 7
“Prolonged repair signaling supports p53 phosphorylation at serine residues, enhancing p53-related gene expression [56].”
Approaches for Identifying Novel Targets in Precision Medicine: Lessons from DNA Repair
Williams, D. T., & Staples, C. J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-60733-7_1 · Cited by 6
Nalabothula, N., Chakravarty, D., Pierce, A. D., & Carrier, F. (2010) · PubMed · Cited by 7
Pham, A. T., Yuan, F., Nagathihalli, N. S., & Dosch, A. R. (2026) · Neoplasia · doi:10.1016/j.neo.2026.101309 · Cited by 5
“Key binding partners for the HEAT motifs binding parters include p53[11], H2AX[12], ATM interating protein (ATMIN)[13], Nibrin (NBS1, a component of MRN complex)[14], and NKX3.”
Wilson, P. F., & Bedford, J. S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5897-7.00001-9 · Cited by 5
UPS and Kinases—Gatekeepers of the G1 /S Transition
Roy, S., Saha, G., & Ghosh, M. K. (2025) · BioFactors · doi:10.1002/biof.70020 · Cited by 5
Sakamoto‐Hojo, E. T., Mello, S. S., Bassi, C. L., Merchi, I. M., Carminati, P. O., Fachin, A. L., Donadi, E. A., & Passos, G. A. S. (2005) · Genome dynamics and stability · doi:10.1007/7050_010 · Cited by 4
“It has been demonstrated that the arrest in the cell cycle is mediated by activation of TP53 by ATM or ATR (Canman et al. 1998; Turenne et al. 2001).”
BackgroundImmunocell-array for Molecular Dissection of Multiple Signaling Pathways in Mammalian Cells
Zanardi, A., Giorgetti, L., Botrugno, O. A., Minucci, S., Milani, P., Pelicci, P. G., & Carbone, R. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t600051-mcp200 · Cited by 4
“damage response, such as p-ATM (27), -H2AX (28), and p53”
BackgroundVos, W. H. D., Meesen, G., Szpirer, C., Scohy, S., Cherukuri, C., Evrard, O., Hutsebaut, X., & Beghuin, D. (2012) · Planetary and Space Science · doi:10.1016/j.pss.2012.07.015 · Cited by 4
“For instance, both NF-kB and p53 are also activated by DNA damage induced by cytotoxic agents or ionizing radiation and this in an ATM and DNA-PK-dependent manner (Basu et al., 1998; Lee et al., 1998; Woo et al., 1998; Turenne et al., 2001; Wu et al., 2006).”
BackgroundTumor microenvironment-activated manganese nanomaterials for precision theranostics
Ahirwar, V. P., Leharwani, M., Alqahtani, T., Shmrany, H. A., Gupta, G., Patil, U. K., & Kesharwani, P. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108180 · Cited by 2
Azemin, W.-A., Alias, N., Ali, A. M., & Shamsir, M. S. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.2017349 · Cited by 1
“Besides, it also phosphorylates other proteins that participated in the DNA-damage response, including p53 (Turenne et al., 2001; Yogosawa & Yoshida, 2018) and their interactions can be seen at 0.999 scores as shown in Figure 3B. Subsequently, it activates the cell cycle checkpoint leading to cell…”
BackgroundInfluential20 Years of DNA Damage Signaling to p53
McLure, K. G., & Kastan, M. B. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_3 · Cited by 2
Metadata
- Authors
- Turenne, G. A., Paul, P., Laflair, L., & Price, B. D.
- Affiliations
- Harvard University (US)
- Corresponding author
- Price, Brendan D
- ORCID
- Price, Brendan D
- Venue
- Oncogene
- Published
- 2001-08-23
- Volume
- 20
- Issue
- 37
- Pages
- 5100-5110
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2098444271
- Cited by
- 120
- References
- 59
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 4 · 2023: 8 · 2022: 9 · 2021: 12 · 2020: 5 · 2019: 4 · 2018: 3 · 2017: 6 · 2016: 3 · 2015: 3 · 2014: 2 · 2013: 3 · 2012: 4
- FWCI
- 3.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA064585, CA64585)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- ATM kinase, p53, p53 transcriptional activation, transactivation domain, DNA damage response, bleomycin, radiosensitivity, cell cycle checkpoints
- MeSH terms
- Antimetabolites, Antineoplastic, Bleomycin, Cell Line, DNA Damage, Dose-Response Relationship, Drug, Dose-Response Relationship, Radiation, Enzyme Activation, Humans, Mutation, Phosphorylation, Precipitin Tests, Serine, Transcription, Genetic, Blotting, Western, Transcriptional Activation, Genes, p53, Tumor Suppressor Protein p53, Mutagenesis, Site-Directed, Protein Serine-Threonine Kinases, Gene Deletion, Protein Structure, Tertiary, Cell Cycle Proteins, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.